1. Home
  2. AZZ vs IRON Comparison

AZZ vs IRON Comparison

Compare AZZ & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AZZ Inc.

AZZ

AZZ Inc.

HOLD

Current Price

$107.02

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$79.40

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZZ
IRON
Founded
1956
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AZZ
IRON
Price
$107.02
$79.40
Analyst Decision
Buy
Strong Buy
Analyst Count
6
13
Target Price
$116.33
$108.85
AVG Volume (30 Days)
193.3K
756.6K
Earning Date
01-07-2026
11-06-2025
Dividend Yield
0.74%
N/A
EPS Growth
855.67
N/A
EPS
10.37
N/A
Revenue
$1,594,766,000.00
N/A
Revenue This Year
$5.21
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$10.40
N/A
Revenue Growth
1.55
N/A
52 Week Low
$70.90
$30.82
52 Week High
$119.95
$99.50

Technical Indicators

Market Signals
Indicator
AZZ
IRON
Relative Strength Index (RSI) 55.82 34.31
Support Level $106.66 $86.75
Resistance Level $110.31 $94.51
Average True Range (ATR) 2.78 4.95
MACD 0.09 -1.40
Stochastic Oscillator 50.76 33.35

Price Performance

Historical Comparison
AZZ
IRON

About AZZ AZZ Inc.

AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: